Merck, known as MSD outside of the United States and Canada, announced that scientific and commercial team leaders will host a virtual investor event where they will give an overview of the company’s advancing HIV treatment and prevention research pipeline on July 17, 2025, at 9:00 a.m. ET.

Investors, analysts, members of the media and the general public are invited to listen to a webcast of the presentation at this weblink. Institutional investors and analysts who would like to ask a question during the session, please dial in using the information on the events page and follow the operator’s instructions.

About Merck’s HIV research pipeline

For an overview of Merck’s HIV treatment and prevention clinical development program, please click here.